CCI Approves Advent International’s ₹3,150-Crore Investment in Yatharth Hospitals

The Competition Commission of India (CCI) has granted approval for private equity giant Advent International to acquire a minority stake in listed healthcare provider Yatharth Hospital and Trauma Care Services Limited. The regulatory clearance paves the way for a ₹3,150-crore primary capital investment into the company.

US-based Advent International is executing the transaction through its Cyprus-incorporated affiliate, Rasmalai Limited, which operates as an investment-holding entity. The CCI announced the approval via a post on X, stating that the commission has approved the acquisition of certain shareholding of Yatharth Hospital and Trauma Care Services Limited by Rasmalai Limited.

The definitive agreement for the ₹3,150-crore primary capital investment was initially announced by Yatharth Hospitals in September. Upon completion of the transaction, Advent International is expected to hold a 24.9 per cent stake in the healthcare provider.

Founded in 2008 and based in Noida, Yatharth Hospital and Trauma Care Services operates a network of super-speciality hospitals. The company provides comprehensive healthcare services, diagnostics, and advanced medical procedures across multiple specialities. Currently, the firm operates nine multi-speciality hospitals housing 2,800 beds, alongside an overall announced capacity of 3,250 beds, positioning it among North India’s fastest-growing listed healthcare providers.

According to the company, the primary capital injection will provide necessary growth funding to support expansion plans and strengthen its healthcare network nationwide. For Advent International, the deal marks an expansion of its footprint within India's growing hospital and healthcare services sector.

The clearance from the anti-trust regulator comes shortly after Yatharth Hospitals released its financial results for the September quarter. The hospital chain reported a 17.45 per cent increase in consolidated net profit, reaching ₹48.45 crore compared to ₹41.25 crore during the corresponding period in the previous year. Revenue from operations for the quarter under review stood at ₹431.42 crore.

"The approval of Advent International's substantial investment by the CCI highlights continued private equity interest in India's healthcare infrastructure. For a regional provider like Yatharth Hospitals, securing ₹3,150 crore in primary capital provides significant financial leverage to scale operations, expand bed capacity, and strengthen its service network amid growing demand for quality medical care." — Dr. Shishir Gupta, Founder & CEO, StartupLanes